[Multicenter cooperation--basis of progression in leukemia treatment].
Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Korobkin Av, Liubimova Ls, Samoĭlova Os, Е. Н. Паровичникова(National Research Center for Hematology Russian Academy of Medical Sciences), Shamanskiĭ Sv, Dunaev IuA, Anchukova Lv, Rekhtman Gb, Lapin Va, Moskov Vi, Pospelova Tn, Rotanova Mn, Khoroshko Nd, Filatov Lb, Konstantinova Ts, Rossiev Va, Domnikova Np, Maliutina Gi, Isaev Vg, Strokin Aa, Gavrilova Lv, Medvedeva Li, Kaporskaia Ts, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Obidina Na, С К Кравченко, Pristupa As, Pilipenko Gv, Kulikov Sm, Khlevnaia Nv, Men'shakova Sn, Zagoskina Tp, Khuazheva Nk, Ziuzgin Is, Kaplanov Kd, Sviridova Ei, Kliasova Ga, Соколова, Tumakov Va, Maksimov Av, Rukavitsyn Oa
PubMed
January 1, 2005
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59